Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $20K 1,700 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $30K 2,797 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 3 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | $50K 4,844 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 6,742 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 6,017 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Holleran KevinDirector, President and CEO | Option exercise · 10b5-1 plan | M | $73K 52.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 15.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Grant or award | A | — 106.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Grant or award | A | — 250.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Vultaggio VincentPAO and PFO | Open-market sale · 10b5-1 plan | SELL | $1,398 556 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 1 | Sieffert Kristen NPresident | Open-market sale · 10b5-1 plan | SELL | $17K 750 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $75K 381 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Barrett David MichaelDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $44K 30.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $192 1 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Tang StanleyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 45.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $26K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $7,449 39 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $4,499 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | — 4,844 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | $1,626 156 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Fang AndyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 10.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Wampler Kira SchererDirector | Option exercise · 10b5-1 plan | M | — 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Alpern Paul LVP and General Counsel | Option exercise · 10b5-1 plan | M | — 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Wampler Kira SchererDirector | Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | $156K 15.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | — 156 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Wampler Kira SchererDirector | Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Holleran KevinDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 52.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Alpern Paul LVP and General Counsel | Option exercise · 10b5-1 plan | M | $2,800 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $4,535 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Fang AndyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 10.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Tang StanleyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 45.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Wampler Kira SchererDirector | Option exercise · 10b5-1 plan | M | — 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 15.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 41 | Malm JoshuaCFO | Open-market purchase | BUY | $7,500 3,750 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 37 | Running Michael J.Regional President - AMER | Open-market sale | SELL | $190K 926 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 36 | Wilcox Jon RDirector | Grant or award | A | — 2,554 sh | Feb 3, 2026 traded Sep 2, 2025 |
| 33 | Dechairo BryanChief Operating Officer | Open-market sale | SELL | $165K 1,662 sh | Feb 3, 2026 traded Feb 2, 2026 |